{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:44:16Z","timestamp":1791150256343,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.1097\/qai.0b013e31821ecf4c","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T07:38:54Z","timestamp":1303803534000},"page":"205-210","source":"Crossref","is-referenced-by-count":73,"title":["Low CD4 Count Is Associated With an Increased Risk of Fragility Fracture in HIV-Infected Patients"],"prefix":"10.1097","volume":"57","author":[{"given":"Michelle K","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian H","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F","family":"Hoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-5-20210131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection.","volume":"42","author":"Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/154510970400300303","article-title":"Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management.","volume":"3","author":"McComsey","year":"2004","journal-title":"J Int Assoc Physicians AIDS Care (Chic Ill)"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"Continuous antiretroviral therapy decreases bone mineral density.","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers.","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00126334-200307010-00001","article-title":"HIV infectiona risk factor for osteoporosis.","volume":"33","author":"Thomas","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-5-20210131","first-page":"145","article-title":"Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.","volume":"84","author":"Aukrust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(88)90576-1","article-title":"Elevated levels of circulating cachectin\/tumor necrosis factor in patients with acquired immunodeficiency syndrome.","volume":"85","author":"Lahdevirta","year":"1988","journal-title":"Am J Med"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191.010k10_3191_3198","article-title":"Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins.","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","article-title":"HMG-CoA reductase inhibitors and the risk of fractures.","volume":"283","author":"Meier","year":"2000","journal-title":"JAMA"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00198-003-1568-z","article-title":"Hip fracture risk in statin users-a population-based Danish case-control study.","volume":"15","author":"Rejnmark","year":"2004","journal-title":"Osteoporos Int"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-139-2-200307150-00009","article-title":"Statin use, clinical fracture, and bone density in postmenopausal women: results from the Womens Health Initiative Observational Study.","volume":"139","author":"LaCroix","year":"2003","journal-title":"Ann Intern Med"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bone.2005.11.001","article-title":"Potential predictive factors of osteoporosis in HIV-positive subjects.","volume":"38","author":"Fausto","year":"2006","journal-title":"Bone"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0736-0266(02)00074-8","article-title":"Tenofovir treatment at 30 mg\/kg\/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta).","volume":"20","author":"Castillo","year":"2002","journal-title":"J Orthop Res"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","article-title":"Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.","volume":"49","author":"Martin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-8529(18)30090-2","article-title":"Glucocorticoids and osteoporosis.","volume":"23","author":"Adler","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1258\/095646206778145640","article-title":"Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines.","volume":"17","author":"Panayotakopoulos","year":"2006","journal-title":"Int J STD AIDS"},{"issue":"Suppl 2","key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2003.11.026","article-title":"Pathophysiology of bone loss in patients receiving anticonvulsant therapy.","volume":"5","author":"Fitzpatrick","year":"2004","journal-title":"Epilepsy Behav"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds.","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk.","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.297.4.387","article-title":"Risk of subsequent fracture after low-trauma fracture in men and women.","volume":"297","author":"Center","year":"2007","journal-title":"JAMA"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jocd.2007.06.001","article-title":"DXA-generated Z-scores and T-scores may differ substantially and significantly in young adults.","volume":"10","author":"Carey","year":"2007","journal-title":"J Clin Densitom"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201107010-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:29:13Z","timestamp":1618039753000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201107010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31821ecf4c","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}